Medical Disclaimer

This is not medical advice

glpfaq.com is a peer-discussion forum and a reference-article resource for people using or considering GLP-1 medications (brand names including but not limited to Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Rybelsus). Everything on this site is for general informational and educational purposes only.

This site does not provide medical advice, diagnosis, or treatment. We are not licensed healthcare providers, and we cannot substitute for them.

Do not rely on this site for medical decisions

Do not use this site to:

• Decide whether to start, stop, increase, decrease, or switch a medication.
• Self-diagnose a condition.
• Self-treat a symptom that could indicate a serious medical problem.
• Replace a consultation with your prescriber, pharmacist, or emergency medical services.

Always consult your own licensed healthcare provider before making any decision about your medication, supplements, diet, or health.

Call someone qualified — not us — for medical help

If you think you are having a medical emergency, including but not limited to:

• Severe abdominal pain (especially radiating to the back)
• Vomiting that won't stop or contains blood
• Black or bloody stools
• Chest pain, difficulty breathing, or fainting
• Sudden severe headache or sudden vision changes
• Signs of low blood sugar (confusion, sweating, fast heartbeat) if you are on other diabetes medications
• Any symptom that feels urgent to you

Call your local emergency number (911 in the US), your prescriber, or go to an emergency department immediately. Do not post on the forum asking what to do.

GLP-1 medications carry specific risks

GLP-1 receptor agonist medications carry serious warnings on their FDA-approved labels, including but not limited to:

• Boxed warning for thyroid C-cell tumors (medullary thyroid carcinoma) — contraindicated in people with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pancreatitis — stop the medication and seek medical attention if you develop severe, persistent abdominal pain.
• Gallbladder disease including gallstones and cholecystitis — may require surgery.
• Acute kidney injury — particularly in the setting of severe vomiting, diarrhea, or dehydration.
• Severe gastrointestinal side effects, including gastroparesis — FDA updated labeling in 2024-2025 to reflect these risks.
• Possible increased risk of suicidal ideation — the FDA and EMA have both evaluated this signal; discuss with your prescriber if you have a history of depression.
• Diabetic retinopathy worsening in patients with pre-existing diabetes.
• NAION (non-arteritic anterior ischemic optic neuropathy) — a signal identified in 2024 for semaglutide; sudden vision changes require urgent evaluation.
• Contraindication in pregnancy — GLP-1s should generally be stopped 2 months before a planned pregnancy.

Read the FDA-approved prescribing information for your specific medication, and discuss its risks with your prescriber.

Content on this site comes from patient experience — not clinical trials

• Reference articles on this site summarize discussions and member experiences from our forum, contextualized with peer-reviewed medical literature and FDA-approved drug labels. They are not clinical research, and individual responses to medications vary substantially.
• When we report that "X members tried Y and Z% reported improvement," we are describing self-reported forum behavior — not controlled trial data. Individual responses vary dramatically.
• Forum posts and discussion threads represent the opinions and experiences of individual users and do not reflect medical consensus. Most are not medically trained.
• We do our best to cite sources, but we are not infallible. If something we've written contradicts your prescriber or the FDA label for your medication, follow your prescriber and the FDA label.

Over-the-counter products and supplements

Where we discuss over-the-counter products (antacids, probiotics, bismuth subsalicylate, etc.), we cite the FDA-approved OTC label directly and link to it. Any dose, timing, or interaction information reflects the label — not our recommendation. Confirm safety with your pharmacist if you take other medications or have kidney, liver, bleeding, salicylate-sensitivity, or other medical conditions.

No doctor-patient relationship

Reading this site, posting on the forum, or exchanging messages with other users — including administrators — does not create a doctor-patient relationship. We cannot be your clinician.

Third-party links

We link to external sites for reference. We do not control and are not responsible for their content.

Minors

This site is intended for adults (18+). Children and adolescents should not use this site, and dosing/medication information on this site is not appropriate for pediatric use. Parents: GLP-1 medications in children require specialized pediatric care — do not apply adult-oriented content to a child's dosing decisions.

By using this site, you acknowledge

That you have read this disclaimer, that you understand it, that you will not rely on this site for medical decisions, and that you will seek qualified medical advice when you need it.

Contact

Questions about this disclaimer: [email protected]. Medical emergencies: call emergency services.